ED
+
Sirtuin enzyme and p53 Computer artwork of a sirtuin (Sir2) enzyme (pink) bound to a p53 peptide (orange) Sir2 enzymes form a unique class of NAD()
ED
+
Japan Aerospace Exploration Agency (JAXA) astronaut Satoshi Furukawa working in the biofabrication facility The 3D biological printer located in the
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening sy
ED
+
November 16 2021 Tokyo Japan - This picture shows a package of N-Nose system for cancer screening test as Japanese biological venture Hirotsu Bio S
ED
+
November 16 2021 Tokyo Japan - This picture shows nematodes move to a side as they attract to urine of a cancer patient in a dish as Japanese biolo
ED
+
November 16 2021 Tokyo Japan - This picture shows nematodes move to a side as they attract to urine of a cancer patient in a dish as Japanese biolo
ED
+
November 16 2021 Tokyo Japan - This picture shows nematodes move to a side as they attract to urine of a cancer patient in a dish as Japanese biolo
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science Shonan RD center head French researcher Eric di Luccio announces a
RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening sy
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening sy
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening sy
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu poses for photo as they developed a screen
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu (L) and French researcher Eric di Luccio (
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu (L) and French researcher Eric di Luccio (
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science Shonan RD center head Eric di Luccio announces as they developed a
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science Shonan RD center head French researcher Eric di Luccio announces a
RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
RF
+
Illustration of a bispecific antibody showing two discrete antigen binding sites (pink and green) within the antibody structure by THOM LEACH SCIE
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science Shonan RD center head French researcher Eric di Luccio announces a
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening sy
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening sy
ED
+
November 16 2021 Tokyo Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening sy
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong is seated in a van as he leaves the Seoul Central District Court in Seo
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (top C) is seated in a van as he leaves the Seoul Central District Cour
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (R) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (R) leaves the Seoul Central District Court in Seoul South Korea to go
RF
+
Illustration of a bispecific antibody (yellow and orange) binding to two different membrane proteins (purple and blue) by THOM LEACH SCIENCE PHOTO
RF
+
Illustration of a bispecific antibody (pink and green) binding to two different membrane proteins (yellow and blue) by THOM LEACH SCIENCE PHOTO LI
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C 2nd row) leaves the Seoul Central District Court in Seoul South Ko
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C 2nd row) leaves the Seoul Central District Court in Seoul South Ko
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong leaves the Seoul Central District Court in Seoul South Korea to go to
RF
+
Illustration of a bispecific antibody (green and light blue) binding to two different membrane proteins (pink and dark blue) by THOM LEACH SCIENCE
RF
+
Illustration of a bispecific antibody (blue and purple) binding to two different membrane proteins (green and orange) by THOM LEACH SCIENCE PHOTO
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C 2nd row) leaves the Seoul Central District Court in Seoul South Ko
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (R) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Lee Jae-Yong June 8 2020 Vice chairman of Samsung Electronics Lee Jae-Yong (C) leaves the Seoul Central District Court in Seoul South Korea to go
ED
+
Editorial use only Expedition 61 Flight Engineer and NASA astronaut Christina Koch handling media bags that enable the manufacturing of organ-like t
RF
+
Illustration of a bispecific antibody showing two discrete antigen binding sites (pink and green) within the antibody structure by THOM LEACH SCI
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (blue) and a cytotoxic payload (orange) for ta
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena displays the new supplement euglena oryzae made from microalgae euglena and aspergi
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena displays the new supplement euglena oryzae made from microalgae euglena and aspergi
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief technology officer Kengo Suzuki display the new material euglena oryzae made
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief technology officer Kengo Suzuki (L) and Akita Konno president Hiroshi Konno (R)
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief technology officer Kengo Suzuki announces the new supplement euglena oryzae m
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief marketing officer Takuyuki Fukumoto announces the new supplement euglena oryza
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief marketing officer Takuyuki Fukumoto announces the new supplement euglena oryza
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief marketing officer Takuyuki Fukumoto displays the new supplement euglena oryzae
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (orange)
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (glowing
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief marketing officer Takuyuki Fukumoto announces the new supplement euglena oryza
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief marketing officer Takuyuki Fukumoto announces the new supplement euglena oryza
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief marketing officer Takuyuki Fukumoto announces the new supplement euglena oryza
ED
+
July 12 2018 Tokyo Japan - Japans biological venture Euglena chief technology officer Kengo Suzuki announces the new supplement euglena oryzae m
ED
+
June 14 2016 Tokyo Japan - Japans electronics giant Hitachi researcher Minoru Sakairi announces Hitachi and Sumitomo Corporations subsidiary Summ
ED
+
June 14 2016 Tokyo Japan - Japans electronics giant Hitachi researcher Minoru Sakairi announces Hitachi and Sumitomo Corporations subsidiary Summ
ED
+
June 14 2016 Tokyo Japan - Japans electronics giant Hitachi researcher Minoru Sakairi announces Hitachi and Sumitomo Corporations subsidiary Summ
ED
+
June 14 2016 Tokyo Japan - Japans electronics giant Hitachi researcher Minoru Sakairi announces Hitachi and Sumitomo Corporations subsidiary Summ
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (orange)
RF
+
Illustration of a human IgG1 (immunoglobulin G1) antibody Colours represent the two light chains (green and yellow) and two heavy chains (blue and pu
ED
+
June 14 2016 Tokyo Japan - Japans electronics giant Hitachi researcher Minoru Sakairi announces Hitachi and Sumitomo Corporations subsidiary Summ
ED
+
A training exercise was held at Tsukiji Subway Station to simulate injuries caused by a chemical agent In an effort to apply the lessons learned from
ED
+
BCastor-oil plant seedsb Seeds of the castor-oil or castor bean plant IRicinus communisi The seeds contain ricin an extremely toxic protein
ED
+
BCastor-oil plant seedsb Seeds of the castor-oil or castor bean plant IRicinus communisi The seeds contain ricin an extremely toxic protein
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - Members of Japans Self-Defense Forces in white protective gear take part in a radioactive decontamination Drill alongsi
ED
+
April 9 2011 Tokyo Japan - A radio-controlled robot is deployed by US Marines from the Chemical Biological Incident Response Force in a radioacti
RF
+
Illustration of a human IgG1 (immunoglobulin G1) antibody Colours represent the two light chains (red and purple) and two heavy chains (cyan and gree
RF
+
Illustration of the ribbon protein structure of a human immunoglobulin G1 (IgG1) antibody Colours represent the two light chains (yellow and red) and
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - A radio-controlled robot is deployed by US Marines from the Chemical Biological Incident Response Force in a radioacti
ED
+
April 9 2011 Tokyo Japan - Radio-controlled robots are deployed by US Marines from the Chemical Biological Incident Response Force in a radioacti
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a Wear
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of the antigen binding site (orange) of a human IgG1 (immunoglobulin G1) antibody by THOM LEACH SCIENCE PHOTO LIBRARY
ED
+
April 9 2011 Tokyo Japan - Members of Japans Self-Defense Forces in white protective gear take part in a radioactive decontamination drill alongsi
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
ED
+
April 9 2011 Tokyo Japan - Wearing gas masks and baggy gray suits US Marines from the Chemical Biological Incident Response Force conduct a radi
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibody technologies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibody technologies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Pheasant-tailed jacana Hydrophasianus chirurgus India by ZoonarRealityImages
482
0
https://www.afloimages.com/search/biologic.html